The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Telomere and telomerase in stem cells
Open accessAbstract
Telomeres, guanine-rich tandem DNA repeats of the chromosomal end, provide chromosomal stability, and cellular replication causes their loss. In somatic cells, the activity of telomerase, a reverse transcriptase that can elongate telomeric repeats, is usually diminished after birth so that the telomere length is gradually shortened with cell divisions, and triggers cellular senescence. In embryonic stem cells, telomerase is activated and maintains telomere length and cellular immortality; however, the level of telomerase activity is low or absent in the majority of stem cells regardless of their proliferative capacity. Thus, even in stem cells, except for embryonal stem cells and cancer stem cells, telomere shortening occurs during replicative ageing, possibly at a slower rate than that in normal somatic cells. Recently, the importance of telomere maintenance in human stem cells has been highlighted by studies on dyskeratosis congenital, which is a genetic disorder in the human telomerase component. The regulation of telomere length and telomerase activity is a complex and dynamic process that is tightly linked to cell cycle regulation in human stem cells. Here we review the role of telomeres and telomerase in the function and capacity of the human stem cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 2×
“To prevent degradation by exonucleases or processing as damaged DNA, the telomere 30 single-strand overhang folds back into the D-loop of duplex telomeric DNA to form a protective ‘T-loop’, which is reinforced with TRF2 and other telomeric DNA-binding proteins named Shelterin (de Lange, 2005).”
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Telomeres and human disease: ageing, cancer and beyond
Blasco, M. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1656 · Cited by 1,434
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 13×
“The association of the telomerase complex with dyskerin suggested that the DKC phenotype may be the result of altered telomerase activity (Vulliamy et al, 2001).”
BackgroundInfluentialSelf-renewal and solid tumor stem cells
Al-Hajj, M., & Clarke, M. F. (2004) · Oncogene · doi:10.1038/sj.onc.1207947 · Cited by 914
Stem Cells and Cancer: Two Faces of Eve
Clarke, M. F., & Fuller, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.011 · Cited by 905
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853 · cited 6×
“TELOMERES AND TELOMERASE IN HEMATOPOIETIC STEM CELLS In the hematopoietic system, telomerase-expressing cells are stem cells with self-renewal potential and their early descendants (Hiyama et al., 1995; Morrison et al., 1996).”
BackgroundInfluentialSelf-citationLoss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.
Vaziri, H., Schächter, F., Uchida, I. A., Wei, L., Zhu, X., Effros, R. B., Cohen, D., & Harley, C. (1993) · PubMed · Cited by 810
Simonsen, J. L., Rosada, C., Serakinci, N., Justesen, J., Stenderup, K., Rattan, S. I. S., Jensen, T. G., & Kassem, M. (2002) · Nature Biotechnology · doi:10.1038/nbt0602-592 · Cited by 805
McEachern, M. J., Krauskopf, A., & Blackburn, E. H. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.331 · Cited by 716 · cited 2×
“For example, some cancers may originate from the transformants of normal stem cells or progenitor cells, so-called cancer stem cells, while aging is induced through a progressive functional decline in certain stem cells (McEachern et al., 2000).”
BackgroundBiologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue
Izadpanah, R., Trygg, C., Patel, B., Kriedt, C., Dufour, J., Gimble, J. M., & Bunnell, B. A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20904 · Cited by 670
Telomerase in the human organism
Collins, K., & Mitchell, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205083 · Cited by 603
DNA methyltransferases control telomere length and telomere recombination in mammalian cells
Gonzalo, S., Jaco, I., Fraga, M. F., Chen, T., Li, E., Esteller, M., & Blasco, M. A. (2006) · Nature Cell Biology · doi:10.1038/ncb1386 · Cited by 544
Murine marrow‐derived mesenchymal stem cell: isolation, in vitro expansion, and characterization
Meirelles, L. D. S., & Nardi, N. B. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04669.x · Cited by 460
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426 · cited 2×
“Recently, Cdkn1a deletion improved stem cell function and lifespan of mice with telomere dysfunction, indicating that upregulation of p21 (encoded by Cdkn1a) in response to shortened telomeres impairs repopulation capacity of stem cells in age-related diseases and senescence (Choudhury et al, 2007).”
BackgroundConditional telomerase induction causes proliferation of hair follicle stem cells
Sarin, K. Y., Cheung, P., Gilison, D., Lee, E., Tennen, R. I., Wang, E., Artandi, M. K., Oro, A. E., & Artandi, S. E. (2005) · Nature · doi:10.1038/nature03836 · Cited by 425
Telomerase Activity in Hematopoietic Cells Is Associated with Self-Renewal Potential
Morrison, S. J., Prowse, K. R., Ho, P., & Weissman, I. L. (1996) · Immunity · doi:10.1016/s1074-7613(00)80316-7 · Cited by 394
Chiu, C., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1996) · STEM CELLS · doi:10.1002/stem.140239 · Cited by 388
Allsopp, R. C., Morin, G. B., DePinho, R., Harley, C. B., & Weissman, I. L. (2003) · Blood · doi:10.1182/blood-2002-07-2334 · Cited by 324
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
Hao, L.-Y., Armanios, M., Strong, M. A., Karim, B., Feldser, D. M., Huso, D., & Greider, C. W. (2005) · Cell · doi:10.1016/j.cell.2005.11.020 · Cited by 302
Dan, Y. Y., Riehle, K. J., Lazaro, C., Teoh, N., Haque, J., Campbell, J. S., & Fausto, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603824103 · Cited by 302
Association between aplastic anaemia and mutations in telomerase RNA
Vulliamy, T., Marrone, A., Dokal, I., & Mason, P. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09087-6 · Cited by 279
Fehrer, C., & Lepperdinger, G. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.006 · Cited by 267
Moriscot, C., de Fraipont, F., Richard, M., Marchand, M., Savatier, P., Bosco, D., Favrot, M., & Benhamou, P. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0123 · Cited by 260
Lack of telomerase activity in human mesenchymal stem cells
Zimmermann, S., Voss, M., Kaiser, S., Kapp, U., Waller, C. F., & Martens, U. M. (2003) · Leukemia · doi:10.1038/sj.leu.2402962 · Cited by 255
Variability at the Telomeres of the Human X/Y Pseudoautosomal Region
Cooke, H. J., & Smith, B. A. (1986) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1986.051.01.026 · Cited by 233
Telomere length in leukocyte subpopulations of patients with aplastic anemia
Brümmendorf, T. H., Maciejewski, J. P., Mak, J., Young, N. S., & Lansdorp, P. M. (2001) · Blood · doi:10.1182/blood.v97.4.895 · Cited by 233
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants
Wynn, R. F., Cross, M. A., Hatton, C., Will, A. M., Lashford, L. S., Dexter, T. M., & Testa, N. G. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08256-1 · Cited by 229
Telomerase activity in human intestine
Hiyama, E., Tatsumoto, N., Kodama, T., Hiyama, K., Shay, J., & Yokoyama, T. (1996) · International Journal of Oncology · doi:10.3892/ijo.9.3.453 · Cited by 203
Self-citationLong-term repopulating ability of telomerase-deficient murine hematopoietic stem cells
Samper, E., Fernández, P., Eguía, R., Martín-Rivera, L., Bernad, A., Blasco, M. A., & Aracil, M. (2002) · Blood · doi:10.1182/blood.v99.8.2767 · Cited by 157
Armstrong, L., Saretzki, G., Peters, H., Wappler, I., Evans, J., Hole, N., von Zglinicki, T., & Lako, M. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0269 · Cited by 153
Telomeres and telomerase in hematologic neoplasia
Ohyashiki, J. H., Sashida, G., Tauchi, T., & Ohyashiki, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205075 · Cited by 145
Telomerase deficiency impairs differentiation of mesenchymal stem cells
Liu, L., DiGirolamo, C. M., Navarro, P. A., Blasco, M. A., & Keefe, D. L. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.031 · Cited by 143
Wright, L. S., Prowse, K. R., Wallace, K., Linskens, M. H. K., & Svendsen, C. N. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.012 · Cited by 134
Dyskeratosis Congenita - A Disease of Dysfunctional Telomere Maintenance
Mason, P., Wilson, D., & Bessler, M. (2005) · Current Molecular Medicine · doi:10.2174/1566524053586581 · Cited by 129 · cited 2×
“For instance, human MSCs (hMSCs) were reported to cease dividing rather early (around 40– 50 population doublings), whereas murine MSCs (mMSCs), that have telomerase activity, could be passaged for more than 100 population doublings (Meirelles Lda and Nardi, 2003).”
BackgroundBrümmendorf, T. H., & Balabanov, S. (2006) · Leukemia · doi:10.1038/sj.leu.2404339 · Cited by 101
Telomere Biology in Aging and Cancer
Wright, W. E., & Shay, J. W. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53492.x · Cited by 99
Lopatina, N., Poole, J. C., Saldanha, S. N., Hansen, N. J., Key, J. S., Pita, M. A., Andrews, L. G., & Tollefsbol, T. O. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01033-7 · Cited by 82
Does the reservoir for self-renewal stem from the ends?
Harrington, L. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207948 · Cited by 77
Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells
Haïk, S., Gauthier, L., Granotier-Beckers, C., Peyrin, J., Lages, C. S., Dormont, D., & Boussin, F. D. (2000) · Oncogene · doi:10.1038/sj.onc.1203596 · Cited by 75
Yanada, S., Ochi, M., Kojima, K., Sharman, P., Yasunaga, Y., & Hiyama, E. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00397.x · Cited by 59
Self-citationTelomere length changes in patients with aplastic anaemia
Lee, J., Kook, H., Chung, I., Na, J., Park, M., Hwang, T., Kwak, J., Sohn, S., & Kim, H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02669.x · Cited by 50
Telomere-to-Centromere Ratio of Bovine Clones, Embryos, Gametes, Fetal Cells, and Adult Cells
Meerdo, L. N., REED, W. A., & White, K. L. (2005) · Cloning and Stem Cells · doi:10.1089/clo.2005.7.62 · Cited by 14
Ancestral telomere shortening: A countdown that will increase mean life span?
Hertzog, R. G. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.034 · Cited by 9
(2003) · PubMed
Cited by
Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
The tumorigenicity of human embryonic and induced pluripotent stem cells
Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889
Targeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.18 · Cited by 529
Soft fibrin gels promote selection and growth of tumorigenic cells
Liu, J., Tan, Y., Zhang, H., Zhang, Y., Xu, P., Chen, J., Poh, Y.-C., Tang, K., Wang, N., & Huang, B. (2012) · Nature Materials · doi:10.1038/nmat3361 · Cited by 468
Metadata
- Authors
- Hiyama, E., & Hiyama, K.
- Venue
- British Journal of Cancer
- Published
- 2007-03-13
- Volume
- 96
- Issue
- 7
- Pages
- 1020-1024
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2163229747
- Cited by
- 548
- References
- 48
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.